Showing results (1-10 of 176) with videos related to
Sort By:
Pageof 18
British Journal of Haematology|September 12, 1998
Elevated TFPI in malignant disease: relation to cancer type and hypercoagulationN Iversen, A K Lindahl, U AbildgaardThrombosis Research|October 15, 1991
The anticoagulant effect in heparinized blood and plasma resulting from interactions with extrinsic pathway inhibitorA K Lindahl, U Abildgaard, R StaalesenHaemostasis|January 1, 1990
Indices of hypercoagulation in cancer as compared with those in acute inflammation and acute infarctionA K Lindahl, P M Sandset, U AbildgaardBlood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1992
The present status of tissue factor pathway inhibitorA K Lindahl, P M Sandset, U AbildgaardHaemostasis|January 1, 1991
Heparin requires both antithrombin and extrinsic pathway inhibitor for its anticoagulant effect in human bloodU Abildgaard, A K Lindahl, P M SandsetThrombosis and Haemostasis|February 1, 1993
Increased plasma thrombomodulin in cancer patientsA K Lindahl, M C Boffa, U AbildgaardBlood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 21, 2000
Tissue factor pathway inhibitor (TFPI) in disseminated intravascular coagulation: low levels of the activated factor X-TFPI complexN Iversen, F G Strekerud, U AbildgaardThrombosis Research. Supplement|January 1, 1991
Involvement of the extrinsic pathway in the activities of low molecular weight heparinsL Norrheim, U Abildgaard, M L Larsen, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1991
Tissue factor pathway inhibitor with high anticoagulant activity is increased in post-heparin plasma and in plasma from cancer patientsA K Lindahl, P B Jacobsen, P M Sandset, et al.Thrombosis Research|November 15, 1996
Binding of tissue factor pathway inhibitor to cultured endothelial cells-influence of glycosaminoglycansN Iversen, P M Sandset, U Abildgaard, et al.Pageof 18